Suchergebnisse - "Fernández-Cruz, Ana"

PubPharm (5)

1

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

enthalten in: Journal of general internal medicine | 2022

von Rubio-Rivas, M. | Mora-Luján, J. | Montero, A. | +23

2

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs : A multicentric real-world study

enthalten in: Cancer medicine | 2021

von Stefania Infante, M. | Fernández-Cruz, A. | Núñez, L. | +30

3

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 : A Meta-analysis

enthalten in: JAMA | 2021

von WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group | Shankar-Hari, M. | Vale, C. | +165

CommentIn: JAMA. 2021 Aug 10;326(6):483-485. - PMID 34228779

4

Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients : SARTRE: a structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Caballero Bermejo, A. | Ruiz-Antorán, B. | Fernández Cruz, A. | +7

5

Infectious and non-infectious neurologic complications in heart transplant recipients

enthalten in: Medicine | 2010

von Muñoz, P. | Valerio, M. | Palomo, J. | +4

1
[1]